$37.96 +0.93 (%) Haemonetics Corp - NYSE

Dec. 17, 2014 | 04:00 PM

Partner Headlines

  1. UPDATE: Barrington Research Assumes Coverage On Haemonetics On Positive Revenue Outlook

    Benzinga | Nov. 20, 2014 | 10:06AM EST
  2. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  3. Midday Losers From November 3: RCS Capital, Haemonetics, Granite Construction And More

    Benzinga | Nov. 3, 2014 | 12:39PM EST
  4. Guru Held Stocks Near Historical Low P/B

    GuruFocus | Jul. 22, 2014 | 19:48PM EST
  5. The Olstein All Cap Value Fund's 2014 First Quarter Letter to Shareholders

    GuruFocus | Jul. 22, 2014 | 18:24PM EST
  6. This Blood Management Company Can Be A Safe Investment

    GuruFocus | Jul. 13, 2014 | 11:08AM EST
  7. Morgan Stanley is Not Surprised by Weak Results/Guidance from Haemonetics

    Benzinga | Apr. 29, 2014 | 09:08AM EST
  8. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 28, 2014 | 10:38AM EST
  9. US Stock Futures Gain Ahead Of Home Sales Report

    Benzinga | Apr. 28, 2014 | 07:27AM EST
  10. Earnings Scheduled For January 27, 2014

    Benzinga | Jan. 27, 2014 | 04:47AM EST
  11. Haemonetics Signs Supply Agreement to Supply HemeXcel with Certain Whole Blood Collection Components

    Benzinga | Jan. 12, 2014 | 17:15PM EST
  12. Mid-Afternoon Market Update: Markets Look to Close in the Green for the Last Session of 2013

    Benzinga | Dec. 31, 2013 | 15:16PM EST
  13. Mid-Day Market Update: Oil Futures Drop; Hertz Global Shares Jump

    Benzinga | Dec. 31, 2013 | 13:04PM EST
  14. Mid-Morning Market Update: Markets Open Higher; Berkshire Hathaway To Acquire Phillips 66 Flow Business For About $1.4B

    Benzinga | Dec. 31, 2013 | 10:56AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Dec. 31, 2013 | 09:28AM EST
  16. US Stock Futures Flat Ahead of Consumer Confidence, House Prices Data

    Benzinga | Dec. 31, 2013 | 06:57AM EST
  17. UPDATE: Jefferies Initiates Coverage on Haemonetics as Stock is Still Dominating Blood Solutions

    Benzinga | Nov. 26, 2013 | 08:53AM EST
  18. Benzinga's Top Initiations

    Benzinga | Nov. 26, 2013 | 07:09AM EST
  19. Meridian Funds Comments on Haemonetics

    GuruFocus | Aug. 28, 2013 | 14:57PM EST
  20. Meridian Funds' Second Quarter 2013 Commentary

    GuruFocus | Aug. 28, 2013 | 14:20PM EST
  21. Meridian Funds' Commentary for Quarter Ended June 30, 2013

    GuruFocus | Aug. 28, 2013 | 14:20PM EST
  22. CONMED Corporation Adds Two New Board Members

    Benzinga | Jul. 30, 2013 | 16:18PM EST
  23. Haemonetics Corporation (HAE) President & CEO Brian Concannon sells 13,000 Shares

    GuruFocus | Feb. 5, 2013 | 07:07AM EST
  24. Mid-Afternoon Market Update: RIMM Falls Further, Endo Health Rises on Exploration of a Sale

    Benzinga | Jan. 30, 2013 | 08:22AM EST
  25. Mid-Day Market Update: BlackBerry 10 Release Sends Shares Lower, Isis Pharma Boosts

    Benzinga | Jan. 30, 2013 | 06:34AM EST
  26. Weekly Guru Bargains Highlights: HAE, DLTR, QCOR, MTX, AMD

    GuruFocus | Jan. 21, 2013 | 06:03AM EST
  27. Weekly Guru Bargains Highlights: CIG, ARO, NKE, DLTR, HAE

    GuruFocus | Jan. 13, 2013 | 12:50PM EST
  28. Weekly Guru Bargains Highlights: CIG, ARO, DLTR, HAE

    GuruFocus | Jan. 13, 2013 | 12:50PM EST
  29. Haemonetics Corporation (HAE) President & CEO Brian Concannon sells 13,000 Shares

    GuruFocus | Jan. 8, 2013 | 11:36AM EST
  30. Allscripts Axes CEO, Ends Plans to Sell Itself

    Benzinga | Dec. 20, 2012 | 07:54AM EST
  31. Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX

    GuruFocus | Dec. 9, 2012 | 14:58PM EST
  32. Haemonetics Corporation (HAE) President & CEO Brian Concannon sells 13,000 Shares

    GuruFocus | Dec. 5, 2012 | 08:38AM EST
  33. Haemonetics Corporation (HAE) President & CEO Brian Concannon sells 6,500 Shares

    GuruFocus | Nov. 5, 2012 | 12:27PM EST
  34. UPDATE: Benchmark Initiates Haemonetics Corporation at Buy on Organic Growth

    Benzinga | Sep. 13, 2012 | 06:02AM EST
  35. Haemonetics Corporation (HAE) CFO & Vice President of Christopher J Lindop sells 61,783 Shares

    GuruFocus | Sep. 6, 2012 | 15:11PM EST
  36. Haemonetics Corp. (HAE) President & CEO Brian Concannon sells 6,500 Shares

    GuruFocus | Aug. 2, 2012 | 13:29PM EST
  37. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga | Jul. 5, 2012 | 12:11PM EST
  38. Haemonetics Corp. (HAE) President & CEO Brian Concannon sells 4,500 Shares

    GuruFocus | Jul. 5, 2012 | 10:20AM EST
  39. ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze with Recombinant Human Hyaluronidase

    Benzinga | Mar. 6, 2012 | 02:45AM EST
  40. Haemonetics Corp. (HAE) President & CEO Brian Concannon sells 5,000 Shares

    GuruFocus | Feb. 2, 2012 | 11:07AM EST
  41. Barrington Research Reiterates Haemonetics Outperform, $73 PT

    Benzinga | Jan. 31, 2012 | 10:35AM EST
  42. Morgan Stanley Reports Haemonetics Recovery On Track

    Benzinga | Jan. 31, 2012 | 01:21AM EST
  43. HAE reaffirmed its full-year guidance

    SchaeffersResearch | Jan. 30, 2012 | 10:30AM EST
  44. Earnings Roundup

    Benzinga | Jan. 30, 2012 | 03:35AM EST
  45. Earnings Scheduled For January 30

    Benzinga | Jan. 29, 2012 | 21:13PM EST
  46. Haemonetics Corp. (HAE) President & CEO Brian Concannon sells 5,000 Shares

    GuruFocus | Jan. 5, 2012 | 04:28AM EST
  47. Sickle Cell Knocks Out NFL Player. Can these Companies Help?

    Benzinga | Jan. 4, 2012 | 05:41AM EST
  48. HAE and TASR reported earnings, AXL unveiled a debt offering, and AMSC axed its planned acquisition

    SchaeffersResearch | Oct. 31, 2011 | 09:23AM EST
Trading Center